Correction: Safety and feasibility of intravenous administration of a single dose of allogenic-Muse cells to treat human cervical traumatic spinal cord injury: a clinical trial. - Koda, Masao; Imagama, Shiro; Nakashima, Hiroaki; Ito, Sadayuki; Segi, Naoki; Ouchida, Jun; Suda, Kota; Harmon Matsumoto, Satoko; Komatsu, Miki; Endo, Toshiki; Suzuki, Shinsuke; Inami, Satoshi; et al. (Stem Cell Research & Therapy, 2024)